NovoCure (NVCR) Current Assets (2014 - 2026)
NovoCure (NVCR) posted Current Assets of $638.5 million for Q2 2026, up 1.09% sequentially from $631.7 million in Q1 2026, and down 41.06% YoY from $1.1 billion in Q2 2025.
NovoCure (NVCR) Current Assets (2014 - 2026) Analysis & Trends
NovoCure has reported Current Assets for 13 years, with the latest figure at $638.5 million in Q2 2026.
- Quarterly Current Assets fell 41.06% year-over-year to $638.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $638.5 million (down 41.06% YoY) and the FY2025 annual result came in at $646.7 million, down 41.56% from the prior year.
- Current Assets grew to $638.5 million in Q2 2026 per NVCR's latest filing, from $631.7 million in the prior quarter.
- Over five years, Current Assets peaked at $1.2 billion in Q3 2025 and troughed at $631.7 million in Q1 2026.
- A 5-year average of $1.0 billion and a median of $1.1 billion in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets gained 9.55% in 2025, then tumbled 42.01% in 2026.
- Over 5 years, Current Assets stood at $1.1 billion in 2022, then declined by 6.94% to $1.0 billion in 2023, then advanced by 6.98% to $1.1 billion in 2024, then sank by 41.56% to $646.7 million in 2025, then slipped by 1.27% to $638.5 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $638.5 million, $631.7 million, and $646.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 638.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 638.52 Mn |
| Mar 31, 2026 | 631.66 Mn |
| Dec 31, 2025 | 646.73 Mn |
| Sep 30, 2025 | 1.20 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.09 Bn |
| Dec 31, 2024 | 1.11 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.00 Bn |
| Dec 31, 2023 | 1.03 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 1.07 Bn |